Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Evaluation of Acute Toxicity in Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer

NCT04913532 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT04913532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04913532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Evaluation of Acute Toxicity in Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Completed
Start date
June 22, 2021
Completion date
July 31, 2025
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant radiotherapy, breast cancer, surgery